Merck KGaA (ETR:MRK) Shares Up 2.7% – What’s Next?

Merck KGaA (ETR:MRK) shot up 2.7% during trading on Thursday . The company traded as high as €106.40 and last traded at €106.15. 317,358 shares were traded during trading, The stock had previously closed at €103.35.

Merck KGaA Trading Down 1.7%

The stock has a market capitalization of $46.78 billion, a price-to-earnings ratio of 17.26, a price-to-earnings-growth ratio of 2.37 and a beta of 0.72. The company has a current ratio of 1.46, a quick ratio of 0.72 and a debt-to-equity ratio of 41.86. The company has a fifty day moving average of €120.26 and a two-hundred day moving average of €117.59.

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing and tools, as well as products that help test nutritional value and identify quality inconsistencies.